- Home
- DSM vs GEVO Comparison
DSM vs GEVO Comparison
Compare DSM & GEVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSM
- GEVO
- Stock Information
- Founded
- DSM 1989
- GEVO 2005
- Country
- DSM United States
- GEVO United States
- Employees
- DSM N/A
- GEVO N/A
- Industry
- DSM Investment Managers
- GEVO Major Chemicals
- Sector
- DSM Finance
- GEVO Industrials
- Exchange
- DSM Nasdaq
- GEVO Nasdaq
- Market Cap
- DSM 270.9M
- GEVO 246.8M
- IPO Year
- DSM N/A
- GEVO 2011
- Fundamental
- Price
- DSM $5.59
- GEVO $1.28
- Analyst Decision
- DSM
- GEVO Buy
- Analyst Count
- DSM 0
- GEVO 2
- Target Price
- DSM N/A
- GEVO $7.58
- AVG Volume (30 Days)
- DSM 161.7K
- GEVO 3.7M
- Earning Date
- DSM 01-01-0001
- GEVO 08-07-2025
- Dividend Yield
- DSM 3.97%
- GEVO N/A
- EPS Growth
- DSM N/A
- GEVO N/A
- EPS
- DSM N/A
- GEVO N/A
- Revenue
- DSM N/A
- GEVO $42,034,000.00
- Revenue This Year
- DSM N/A
- GEVO $1,022.79
- Revenue Next Year
- DSM N/A
- GEVO $12.26
- P/E Ratio
- DSM N/A
- GEVO N/A
- Revenue Growth
- DSM N/A
- GEVO 145.38
- 52 Week Low
- DSM $4.69
- GEVO $0.48
- 52 Week High
- DSM $6.05
- GEVO $3.39
- Technical
- Relative Strength Index (RSI)
- DSM 48.92
- GEVO 54.42
- Support Level
- DSM $5.53
- GEVO $1.19
- Resistance Level
- DSM $5.64
- GEVO $1.41
- Average True Range (ATR)
- DSM 0.04
- GEVO 0.08
- MACD
- DSM 0.00
- GEVO 0.02
- Stochastic Oscillator
- DSM 64.29
- GEVO 58.06
About DSM BNY Mellon Strategic Municipal Bond Fund Inc.
BNY Mellon Strategic Municipal Bond Fund, Inc. is a diversified closed-end management investment company. Its investment objective is to seek to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital.
About GEVO Gevo Inc.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.